An Expanded Access Program for VO (RP1) in Combination With Nivolumab in Patients With Advanced Melanoma

NCT06590480 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL: RP1
BIOLOGICAL: Nivolumab

Sponsor

Replimune, Inc.